{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:58:30Z","timestamp":1791413910945,"version":"4.3.3"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Cancer"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Breast cancer (BC) and lung cancer are the two most common malignancies among women in China. As breast cancer diagnostic and therapeutic technologies continue to advance, the lifespan of patients with breast cancer has been extended, and the number of breast cancer patients with second primary lung cancer (SPLC) has increased. Furthermore, among women with SPLC, breast cancer stands as the most prevalent initial malignancy, and SPLC remains the predominant cause of mortality within this demographic. The aim of this retrospective study was to analyze the clinical characteristics of breast cancer with SPLC patients and to investigate postoperative survival and prognostic factors. This retrospective study analyzed 150 patients diagnosed with primary lung cancer in BC at one cancer center in China from January 2000 to December 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed demographic data, cancer characteristics, treatment modalities, and survival outcomes. Survival curves were generated using the Kaplan\u2013Meier method, and the significance of survival differences among selected variables was verified using the log\u2010rank test. A univariate Cox regression analysis was used for estimating hazard ratios. A multivariate Cox regression analysis with a backward elimination method was used to estimate hazard ratios and to identify independent prognostic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 29 cases (19.3%) of death. The median follow\u2010up time for this cohort was 96.3\u2009months. The median OS was calculated at 60.0\u2009months, with survival rates at 1\u2010, 3\u2010, 5\u2010, and 10\u2010year marked at 89.7%, 65.5%, 44.8%, and 10.3%. The median time from BC surgical treatment to the occurrence of SPLC was observed at 4.5\u2009months. A peak period of SPLC occurs in the first year after BC surgery. The median follow\u2010up time from SPLC surgical treatment to death or the end of follow\u2010up was 73.5\u2009months. The median survival time from SPLC surgical treatment to death by any cause was 39.2\u2009months, with survival rates at 1\u2010, 3\u2010, and 5\u2010year marked at 86.2%, 51.7%, and 31.0%, and survival rates were 0% at the 9th year. The average age at BC diagnosis was 53.8\u2009\u00b1\u200910.4\u2009years (range 25\u201381). 41.3% of patients had other chronic diseases. The average menarche age was 14.7\u2009\u00b1\u20091.5\u2009years (range 11\u201320). 64.7% of patients had menopause. Independent prognostic factors for the BC with SPLC by multivariate analysis were the status of menopause and T\u2010stage of SPLC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Further analysis revealed that patients who were menopausal and had a poor T stage of SPLC had a higher mortality rate. Based on these findings, future studies should focus on the menstrual status, hormone levels, and pathological stage of SPLC in BC patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1759-7714.70051","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T02:47:26Z","timestamp":1744685246000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival Analysis of Secondary Primary Lung Cancer After Breast Cancer Patients: Insights From a Retrospective Single\u2010Center Study of Clinical Outcomes and Prognostic Indicators"],"prefix":"10.1111","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-0300","authenticated-orcid":false,"given":"Miao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-2681","authenticated-orcid":false,"given":"Qian","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9364-394X","authenticated-orcid":false,"given":"Jiagen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.0270"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7554\/eLife.86379","article-title":"Risk of Second Primary Cancers After a Diagnosis of First Primary Cancer: A Pan\u2010Cancer Analysis and Mendelian Randomization Study","volume":"12","author":"Ruan X.","year":"2023","journal-title":"eLife"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01426"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00427"},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.515606","article-title":"Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population\u2010Based Study","volume":"10","author":"Song C.","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.25223"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.02.011"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100903"},{"issue":"1","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102203","article-title":"Long\u2010Term Second Primary Cancer Risk in Adolescent and Young Adult (15\u201339\u2009Years) Cancer Survivors: A Population\u2010Based Study in The Netherlands Between 1989 and 2018","volume":"9","author":"Meer D. J.","year":"2024","journal-title":"ESMO Open"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34671"},{"issue":"1","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","DOI":"10.1002\/cnr2.1927","article-title":"Risk Factors of Developing Contralateral Breast Cancer After First Primary Breast Cancer Treatment","volume":"7","author":"Avatefi M.","year":"2024","journal-title":"Cancer Reports (Hoboken)"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2024.08.017"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2021-056535"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107295"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2023.04.007"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.001"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278040"},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fonc.2019.00525","article-title":"Co\u2010Administering Melatonin With an Estradiol\u2010Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2\u2010Positive Breast Cancer","volume":"9","author":"Dodda B. R.","year":"2019","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002335"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwaa210"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003731"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012603"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11669"},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.603378","article-title":"Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1\u20103N0M0 Non\u2010Small Cell Lung Cancer","volume":"10","author":"Wang G.","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S172818"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.08.025"},{"key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2147\/CMAR.S374648","article-title":"Research Progress on Radiotherapy Combined With Immunotherapy for Associated Pneumonitis During Treatment of Non\u2010Small Cell Lung Cancer","volume":"14","author":"Zhang A.","year":"2022","journal-title":"Cancer Management and Research"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.239"},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111012","article-title":"Anti\u2010PD\u2010L1 \u00d7 Anti\u2010CD3 Bispecific T\u2010Cell Engager\u2010Armed T Cells Can Overcome Immunosuppression and Redirect T Cells to Kill Breast Cancer Cells Expressing PD\u2010L1","volume":"124","author":"Luangwattananun P.","year":"2023","journal-title":"International Immunopharmacology"}],"container-title":["Thoracic Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.70051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T03:08:11Z","timestamp":1744686491000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1759-7714.70051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/1759-7714.70051"],"URL":"https:\/\/doi.org\/10.1111\/1759-7714.70051","archive":["Portico"],"relation":{},"ISSN":["1759-7706","1759-7714"],"issn-type":[{"value":"1759-7706","type":"print"},{"value":"1759-7714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70051"}}